Clinical and molecular characteristics of responders versus non-responders to immune checkpoint inhibitors (ICI) in NSCLC. Shah, A., Padda, S. K., Neal, J. W. AMER SOC CLINICAL ONCOLOGY. 2019

View details for DOI 10.1200/JCO.2019.37.8_suppl.114

View details for Web of Science ID 000489109600120